Ensysce Biosciences ENSC
NASDAQ ENSC
$0.37 -0.01 (-2.69%)
As of: Aug 21, 2026 · 9:55 AM EDT

Ensysce Biosciences (ENSC) Debt Ratio (2019 - 2025)

Ensysce Biosciences (ENSC) posted quarterly Debt Ratio of 0.04 for Q4 2025, down 23.64% year-over-year from 0.05 in Q4 2024, and down 66.25% quarter-over-quarter from 0.12 in Q3 2025.

Ensysce Biosciences (ENSC) Debt Ratio (2019 - 2025) Analysis & Trends

Ensysce Biosciences (ENSC) has reported Debt Ratio for 7 consecutive years, with 0.04 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Debt Ratio fell 23.64% year-over-year to 0.04; the TTM figure through Dec 2025 stood at 0.04 (down 23.64% YoY), while the FY2025 annual figure was 0.04, down 23.64% from the prior year.
  • Debt Ratio fell to 0.04 in Q4 2025 per ENSC's latest filing, from 0.12 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.17 in Q3 2022 and bottomed at 0.02 in Q4 2022.
  • Historically, Debt Ratio has averaged 0.25 across 5 years, with a median of 0.09 in 2023.
  • On a YoY basis, Debt Ratio climbed as much as 2001.27% in 2021 and fell as far as 97.76% in 2021.
  • Ensysce Biosciences' Debt Ratio stood at 0.27 in 2021, then sank by 91.2% to 0.02 in 2022, then jumped by 1225.3% to 0.32 in 2023, then slumped by 82.92% to 0.05 in 2024, then dropped by 23.64% to 0.04 in 2025.
  • Business Quant data shows ENSC's Debt Ratio at 0.04 in Q4 2025, 0.12 in Q3 2025, and 0.08 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 138.53 Bn 130.68 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.34 Bn 78.35 Bn 3.93 Bn 0.05
3 Argenx Se 64.67 Bn 59.48 Bn 1.37 Bn -
4 Moderna 59.04 Bn 53.90 Bn 52.00 Mn 0.05
5 BeOne Medicines 42.03 Bn 36.94 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 30.78 Bn 27.47 Bn 992.69 Mn -
7 BioNTech SE 27.81 Bn 9.42 Bn 668.28 Mn 0.03
8 Insmed 27.21 Bn 26.05 Bn 358.27 Mn 0.26
9 Royalty Pharma 26.99 Bn 26.15 Bn - 0.47
10 Ensysce Biosciences 941,114.74 -3.37 Mn - 0.04

Historic Data

Download Data
DateValue
Dec 31, 2025 0.04
Sep 30, 2025 0.12
Jun 30, 2025 0.08
Mar 31, 2025 0.06
Dec 31, 2024 0.05
Sep 30, 2024 0.04
Jun 30, 2024 0.16
Mar 31, 2024 0.05
Dec 31, 2023 0.32
Sep 30, 2023 0.11
Jun 30, 2023 0.07
Dec 31, 2022 0.02
Sep 30, 2022 1.17
Jun 30, 2022 0.53
Mar 31, 2022 0.07
Dec 31, 2021 0.27
Sep 30, 2021 0.90
Jun 30, 2021 0.44
Dec 31, 2020 12.07
Sep 30, 2020 0.04